Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CPB✓SelectedUSD · CPBGSK vs CPB performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs CPB

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
CPB return
-31.5%
Excess return
+78.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioCPBExcessAlpha
1D-0.1%+3.0%-3.1%-0.7%
7D-1.3%+2.6%-3.9%-1.8%
30D+2.7%+18.0%-15.3%-0.7%
3M+2.7%+2.5%+0.2%+1.8%
6M+3.3%+20.7%-17.4%-1.0%
YTD+6.5%-10.5%+16.9%+7.9%
1Y+10.7%-20.3%+30.9%+14.8%
3Y+64.4%-34.5%+98.9%+76.2%
5Y+46.7%-30.7%+77.4%+52.6%
All+46.7%-31.5%+78.2%+52.6%

Cumulative growth

Daily Returns

Daily percentage return beside CPB.

Daily Out/Under-Performance

Portfolio return minus CPB return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CPB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded CPB wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling